Clinical Trial Update March 2026 - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Clinical Trial Update March 2026

Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.

  • March 1, 2026

  • 40 min

Share

  • 1

    The article provides updates on various clinical trials for age-related macular degeneration (AMD) and related conditions.

  • 2

    A Phase 1 study of ABF-101 aims to evaluate its safety and tolerability in participants with AMD.

  • 3

    CTx001 is being tested in a Phase 1/2 trial for safety and efficacy in geographic atrophy secondary to AMD.

  • 4

    Multiple studies are assessing the safety and efficacy of intravitreal injections for geographic atrophy associated with AMD.

  • 5

    SGLT2 inhibitors are under investigation for their potential effects on geographic atrophy related to AMD.

Original Source(s)

Clinical Trial Update March 2026

  • March 1, 2026

Related Content

Emphasis on Vitreoretinal Surgery

Upfront: Monthly reflection by Editor in Chief Diana V. Do, MD.

Why Uveitis Fellowship Deserves a Second Look

Uveitis Corner: Survey data and specialist insights challenge long-standing misconceptions about uveitis training, surgery, and compensation.

New Appointment for The Retina Clinic London

Clinic expands cataract and medical retina expertise with appointment of consultant ophthalmic surgeon

  • July 13, 2026

  • 2 min